Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
How much is the Tuberculosis Diagnostics Market valued at in 2026, and what valuation is forecast for 2030?
The tuberculosis diagnostics market has demonstrated robust expansion in recent years. It is projected to grow from $2.34 billion in 2025 to $2.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. The growth observed in the historic period can be ascribed to the global tuberculosis disease burden, the expansion of public health screening programs, the availability of smear microscopy infrastructure, international funding for tb control, and the adoption of culture-based diagnostics.
The tuberculosis diagnostics market is projected to experience substantial expansion in the coming years, reaching $3.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. This expansion during the forecast period is propelled by factors such as an increasing need for swift and precise TB diagnosis, a heightened emphasis on identifying drug-resistant TB, the proliferation of decentralized diagnostic testing, escalating capital in molecular diagnostics, and the incorporation of AI-powered diagnostic instruments. Key developments anticipated in this period encompass the wider acceptance of molecular TB testing approaches, the increased utilization of rapid diagnostic systems, a broader inclusion of drug resistance detection capabilities, the spread of point-of-care TB testing, and a stronger emphasis on diagnostics offering high sensitivity.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp
What Drivers Are Influencing The Growth Of The Tuberculosis Diagnostics Market?
The increasing occurrence of tuberculosis is fueling the demand within the tuberculosis diagnostics market moving forward. Tuberculosis (TB), a highly communicable bacterial infection primarily targeting the lungs, necessitates prompt identification to avert serious complications and spread. The escalation in TB incidence stems from the growing prevalence of HIV/AIDS, which significantly weakens the immune system, rendering individuals highly vulnerable to developing active tuberculosis disease. This heightened incidence of tuberculosis consequently bolsters the tuberculosis diagnostics sector by elevating the need for swift, precise, and point-of-care diagnostic tests that facilitate early initiation of treatment and improved disease management. As an illustration, in October 2025, the UK Health Security Agency, the governmental body overseeing health security in England, reported that Tuberculosis levels in England saw a 13.6 percent rise in 2024 compared with 2023, with 5,490 notifications recorded in 2024 against 4,831 in 2023. Consequently, the uptick in tuberculosis incidence is propelling the expansion of the tuberculosis diagnostics market.
What Segments Are Included Within The Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques
Which Market Trends Are Opening Growth Opportunities In The Tuberculosis Diagnostics Market?
Leading companies within the tuberculosis diagnostics market are prioritizing product innovation and the development of new solutions, such as tuberculosis diagnostic tests, to solidify their market position. Tuberculosis diagnostic tests are medical examinations and laboratory techniques specifically designed to detect the presence of Mycobacterium tuberculosis, the bacteria responsible for TB. These tests are crucial for identifying active TB disease, latent TB infection, and drug-resistant strains, enabling prompt and appropriate treatment. For example, in February 2023, Redcliffe Labs, an India-based technology-driven diagnostics service provider, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test allows clinicians to rapidly screen for tuberculosis and multidrug resistance as a first-line assessment, performed using the BD MAX molecular diagnostic system. Clinicians utilize this test to simultaneously identify the bacteria causing TB and determine if these bacteria carry mutations associated with resistance to two key first-line drugs, Isoniazid (INH) and Rifampicin (RIF).
Who Are The Primary Competitors In The Global Tuberculosis Diagnostics Market?
Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report
Which Regions Are Poised For Strategic Growth In The Tuberculosis Diagnostics Market?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Tuberculosis Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp
Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2026, By The Business Research Company
Infectious Disease Diagnostics Testing Global Market Report 2026
Medical And Diagnostic Laboratory Services Global Market Report 2026
Clinical Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company